A Common Polymorphism in the Cannabinoid Receptor 1 (CNR1) Gene is Associated with Antipsychotic-Induced Weight Gain in Schizophrenia | Neuropsychopharmacology
India says it has no concern about AstraZeneca vaccine side effects | Reuters
S.Africa wants to return 1 mln AstraZeneca vaccine doses to Serum Institute-report | Reuters
Journey to the Center of the Earth by Jules Verne | Goodreads
Nuovo Coronavirus: quanto dura l'immunità della vaccinazione Covid-19 e la terza dose - Ospedale Pediatrico Bambino Gesù
AstraZeneca says CEO Pascal Soriot to host call on results | Reuters
Broker says Astra's Crestor may face patent threat | Reuters
S.Africa wants to return 1 mln AstraZeneca vaccine doses to Serum Institute-report | Reuters
Factbox-Astra-Oxford vaccine: what's been said about dosage and efficacy | Reuters
AstraZeneca fights Pfizer bid by predicting sales surge - eventually | Reuters
Denmark's health authority deems AstraZeneca COVID-19 vaccine may be given on voluntary basis: Ritzau | Reuters
AstraZeneca wins early U.S. approval for blood cancer drug | Reuters
AstraZeneca breast cancer treatment gets FDA priority review | Reuters
AstraZeneca boosts respiratory unit with $575 million Takeda deal | Reuters
UK medicine regulator to assess best dose regimen of Oxford/AstraZeneca COVID vaccine | Reuters
Quanto ha fatto guadagnare il vaccino ad AstraZeneca? - Startmag
Verbale n. 25 del 7 giugno 2021
Treatment for Chronic Obstructive Pulmonary Disease | BREZTRI AEROSPHERE
No evidence blood clots more likely after AstraZeneca shot, says UK PM's spokesman | Reuters
Philippines secures 2.6 million doses of AstraZeneca's COVID-19 vaccine | Reuters
So pleased' - Britain gives first dose of Oxford/AstraZeneca vaccine to dialysis patient | Reuters
U.S., AstraZeneca strike deal for COVID-19 antibody treatment touted by Trump | Reuters
Germany sees rapid EU approval of AstraZeneca's COVID-19 vaccine | Reuters
Londres dice que la vacuna de Astrazeneca evita la muerte por COVID-19 tras suspenderse su uso en Sudáfrica | Reuters
Chile, Peru green-light AstraZeneca COVID-19 vaccine trials | Reuters
